Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Commit... (tion research andadvocacy. SHM's members...)

Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM

Date:3/11/2008

tion, research and advocacy. SHM's membership is comprised of approximately 6,000 hospitalists, as of December 2006, with approximately 20,000 in the profession overall. It is expected that there will be upwards of 30,000 in the hospitalist profession by the end of the decade.

About Ingenious Med

Ingenious Med was founded in 1999 by a group of practicing hospitalist leaders and has a customer base comprising thousands of users in over 500 facilities across the United States. Ingenious Med's flagship product, IM Practice Manager is an Internet-based application that enables inpatient physicians to capture charges, improve their quality of care, and communicate digitally with their peers and administrators. In addition, the program aggregates management data separately from the hospital information system, so individual physician and total department performance can be accurately evaluated. Nationwide, they are the leader in inpatient practice management solutions, and have recently responded to increasing demand for their product- lines in specialty groups.

For more detailed information on Ingenious Med, visit http://www.ingeniousmed.com or call (404)-815-0862.

SOURCE Ingenious Med
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Stevens Health, Technology and Society roundtable: Sept. 19
2. Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase
3. Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign
4. Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
5. NCPA President Steve Girouxs Testimony at FDA Behind the Counter Hearing
6. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
7. Play by Steve Nash, Assisted by Milk
8. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study
9. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse
10. Stevens UV expert at Science-on-Saturday program
11. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations

Post Your Comments:

(Date:12/7/2009)... 7 Interleukin Genetics, Inc. (NYSE Amex: ... the State of New York,s Department of Health for ... Genetic Test that determines predisposition to severe periodontal disease ... all other States in the U.S. However, through ... the accuracy and reliability of results of laboratory tests, ...

(Date:12/7/2009)... Health Service (NHS), which manages 500 hospitals and over ... of an engaged staff: healthier and happier patients. As ... of care, many NHS hospitals are teaming up with ... train hospital leaders. ,, "Staff engagement is essential to ... Weeks, policy manager for NHS Employers, an organisation that ...

(Date:12/7/2009)... selected a Texas Wind Integration project team including Drummond Group ... smart grid demonstration project. Drummond Group,s role is overseeing the ... with strong support from the project stakeholders. , ... ... -- The Department of Energy has selected a ...

(Date:12/7/2009)... tax return by using the free tax calculator. Answer simple questions about ... ... can estimate their 2009 tax return by using the free tax calculator. , ... understand it. No more waiting or worrying about how much the return will ... everyone can use., , , Find out right now with a few ...

(Date:12/7/2009)... the University of Chicago have discovered a technique that ... sleep apnea (OSA) or habitual snoring by screening their ... of developing a relatively simple urine test that could ... need for costly and inconvenient sleep studies in children ... whom actually have OSA," said lead author David Gozal, ...

Breaking Medicine News(10 mins):Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 2 Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 3 Health News:The NHS to Improve Patient Care by Better Engaging Staff 2 Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 2 Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 3 Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 4 Health News:2009 Free Tax Return Calculator 2 Health News:Urine test for pediatric obstructive sleep apnea possible 2

[0] Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York [0] The NHS to Improve Patient Care by Better Engaging Staff [0] Drummond Group Awarded DOE Funds for Texas Wind Integration Project [1] 2009 Free Tax Return Calculator [0] Urine test for pediatric obstructive sleep apnea possible

... Institute (BHI) announced today that it is joining the ... of Women,s Health (OWH), in promoting National Women,s Health ... is part of BHI,s campaign to promote hearing health ... BHI is offering an online hearing test, the Across ...

... Anesthetix Management, LLC ("Anesthetix"), recently marked a new milestone, expanding ... more hospitals are learning about and embracing Anesthetix, unique value ... national platform and local delivery model over a wide geographic ... ...

... variety of markets and are used in a wide range of ... that require pivoting capability and where visual, cosmetic appeal may be ... assemble and more cost effective than the traditional hinge. Click ... Reell,s Torque Insert in use! , ...

... EL SEGUNDO, Calif., April 27 DaVita Inc. (NYSE: ... 2009. Net income attributable to DaVita Inc. for the three months ... as compared to $86.9 million, or $0.80 per share, for the ... operating highlights include: , , ...

... BioTrends Research Group, Inc. released TreatmentTrends(R): US Nephrology, ... over 200 US Nephrologists.In the ESA market, changes that ... product level, while the overall use of ESAs has ... Among patients with Chronic Kidney Disease not on ...

... Illnesses Occurring Now is ,North American Flu,WASHINGTON, April 27 ... media to cease inaccurate references to swine flu because ... World Organization for Animal Health (OIE), North American Flu ... has affected people in North America," said AMI President ...

Better Hearing Institute Joins HHS, Office on Women's Health in Promoting National Women's Health Week and Hearing Health Anesthetix Grows Practice Operations to 10 States Reell Precision Manufacturing Creates a New Category of Torque Control Hinges, Check Out the Reell Torque Insert DaVita 1st Quarter 2009 Results Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group Media Urged to Correct Inaccurate References to 'Swine Flu'

(Date:12/4/2009)... The U.S. Food and Drug Administration (FDA) today approved ... the treatment of schizophrenia and manic or mixed episodes ... years old. ,, The updated Zyprexa label states ... for weight gain and hyperlipidemia in adolescents compared to ...

(Date:12/4/2009)... (Nasdaq: ONXX ) today announced that it will ... will discuss the data presentations surrounding carfilzomib in relapsed ... American Society of Hematology (ASH) Annual Meeting. ,, The ... on Monday, December 7, 2009. The live webcast ...

(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...

Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6 FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7 Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2 U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2 Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1 Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2 Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3 Omega 3 EPA 3A Treatment for a Heart Condition 48552 1 Omega 3 EPA 3A Treatment for a Heart Condition 48552 2 Omega 3 EPA 3A Treatment for a Heart Condition 48552 3 Omega 3 EPA 3A Treatment for a Heart Condition 48552 4 Omega 3 EPA 3A Treatment for a Heart Condition 48552 5 Omega 3 EPA 3A Treatment for a Heart Condition 48552 6 Three Year Agreement for Surgical Instrument Repair Services 48550 1 Three Year Agreement for Surgical Instrument Repair Services 48550 2

[0] FDA Approves Lilly's Zyprexa for Two Adolescent Indications [0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS

... insight for physicians, NATICK, Mass. and WASHINGTON, ... ) today announced results from an analysis,of the ... by the,Cardiovascular Research Foundation (CRF) with research grant ... MDCO ) is designed to,determine the safety ...

... Susan G. Komen for the,Cure(R) recently announced the ... American and international scientists this year alone,to fast ... by local Komen,Affiliates., Two researchers from the ... School of Medicine, Julie Boerner, Ph.D., assistant,professor, and ...

Other Medicine Technology:HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients 2 HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients 3 HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients 4 Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 2 Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 3 Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 4 Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 5

HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 9.0 mm and length 7.5 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard crankshaft-type 1/1 (mm), opening width 7.0 mm and length 5 mm....

Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....

Medicine Products:

Sugita Aneurysm Clip 70 Angled To L(S)Sugita Aneurysm Clip Angled (M)Sugita Aneurysm Clip Sugita Aneurysm Clip L-Shaped Cvd. To R(M)

Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Commit...(tion research andadvocacy. SHM's members...),Health